In 2023, funds of funds (FoFs) are on track to raise the smallest amount of money in more than a decade. At the same time, muted venture deal activity has many firms ditching their follow-on funds. De
The International Space Station has a monopoly on in-space research, but the huge surge of interest in commercial space is starting to change that. Atmos Space Cargo, a German startup, is looking to o
Life science businesses like big pharmaceutical companies have a singular set of needs when it comes to building applications. Their models and algorithms tend to be more sophisticated and data-intens
As interest around large AI models — particularly large language models (LLMs) like OpenAI’s GPT-3 — grows, Nvidia is looking to cash in with new fully managed, cloud-powered service
Moderna filed a lawsuit against Pfizer and BioNTech claiming the biopharmaceutical companies infringed on Moderna’s patents related to mRNA technology in development of their COVID-19 vaccine. The l
Between one-to-one therapy and free online forums, people search for a range of solutions to mental health therapy online. Especially since the pandemic increased anxiety and depression rose by 25% gl
Pandas connects Latin America's small businesses directly with Asian manufacturers to reduce logistical problems and high fees often imposed by importers and intermediaries.
Historically, continuous tracking of an individual’s vital signs meant they had to be in a hospital. But that's not true anymore.
Planetary aims to bring all of the alternative protein production planets into orbit with its scaling technology.
We believe in a future where psychedelic therapy will be as common as going to the dentist, but the path won’t be easy.
A startup spawned from a lab at the University of California, Berkeley has won investor support to work on its patented needle-free injector, which it hopes can make therapies that traditionally requi
Cellino Bio’s founder Nabiha Saklayen didn’t initially intend to enter TechCrunch Disrupt 2021’s Startup Battlefield — it was her PR advisor who threw the startup’s name in the ring as a
Novo, the startup building a new kind of banking service from the ground up for small and medium businesses, has closed a significant round of funding to take the next step in growing its platform. It
Nabla Bio, a Boston, Massachusetts based startup, announced a $11 million seed round on Monday. The company, founded in May 2020, is looking to enter the increasingly competitive space of antibody des
Vinehealth, a 2018-founded, London-based digital health startup that’s built an app offering personalized support for cancer patients while also making it easier to gather patient-reported outco
Adil estimates that today’s growth factor costs $2 million per gram to make, but she believes that with efforts from Tiamat Sciences and others, that cost could come down 10 times.
The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round. Generate Biomedicines
Medable has grown 300% in the past year and over 800% in the last 18 months, which CEO Michelle Longmire said was proof that a patient-centered approach is taking hold.
It’s hard to argue that any technology company has had a greater impact in the past decade than BioNTech, the mRNA-based therapeutics pioneer behind the world’s most widely-used COVID-19 v
On Monday, a 17-year drought in the world of Alzheimer’s drugs ended with the FDA approval of Biogen’s Aduhlem (aducanumab). The controversy behind the FDA’s decision was considerable, but it do
Load More